Situated in Digwal, Piramal's plant provides API (NCEs & generics) and intermediate development through commercial production. Its extensive infrastructure includes over 12 multi-purpose blocks across three zones, boasting a total capacity exceeding 750 kL via 245 reactors. The facility holds approvals from USFDA, EDQM, AIFA, and KFDA. https://www.piramalpharmasolutions.com/facilities/commercial-api-manufacturing-digwal?utm_source=article-submission&utm_medium=userbookmark&utm_campaign=ppsxclaxarticlesubmission